Acronym
3g092517
Code
3G092517
Duration
01 January 2017 → 31 December 2020
Funding
Research Foundation - Flanders (FWO)
Promotor
Research disciplines
-
Medical and health sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other basic sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other clinical sciences
- Other health sciences
- Nursing
- Other paramedical sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other translational sciences
- Other medical and health sciences
Keywords
cancer
Project description
The aim of this project is to develop nanoparticles that – upon targeted uptake by tumor cells – disassemble into soluble polymers. Subsequently, these polymers will position themselves on the cell surface and bind to endogenous antibodies, thereby provoking an immune response against the tumor cells.